secwatch.observer — SEC 8-K summary
======================================

Issuer:     T2 Biosystems, Inc. (—)
CIK:        0001492674
Form:       8-K
Filed at:   2025-04-07T23:59:59+00:00
Accession:  0001193125-25-073558
Event type: leadership
Sentiment:  negative
Materiality: 0.95
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

T2 Biosystems loses entire board and top management; appoints turnaround specialist as CEO
--------------------------------------------------------------------------------

- Directors John Sperzel and Robin Toft resigned March 31; Cumming, Elsbree, Toft, Liebman, Adams resigned April 3.
- Michael Gibbs resigned as SVP/GC/Secretary March 18; John Sperzel as CEO/President March 31; John Sprague as CFO/Treasurer April 3.
- Board appointed Craig Jalbert as CEO, President, Treasurer, Secretary, and Class I director effective April 3, 2025.
- Jalbert is a principal at Verdolino & Lowey, P.C., focusing on distressed businesses; compensated $50,000/year.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1492674/000119312525073558/0001193125-25-073558-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1492674/000119312525073558/d919843d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-073558

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer